期刊文献+

散发性包涵体肌炎的MRI表现 被引量:1

The application of MRI in sporadic inclusion-body myositis
原文传递
导出
摘要 目的分析散发性包涵体肌炎(sIBM)的MRI特征性表现。方法回顾性分析2013年5月至2014年11月经肌肉病理检查确诊的6例sIBM患者的临床及影像资料。所有患者均表现为缓慢发展的下肢无力,大腿肌肉活检证实为散发性包涵体肌炎。所有患者均进行大腿肌肉MRI检查,结合MRI影像对患者大腿肌肉脂肪浸润、水肿、萎缩情况进行评估。结果6例患者均表现为不同程度的脂肪浸润,12块肌肉脂肪浸润受累频率由高到低分别为臀大肌(6例)、股外侧肌(6例)、股中间肌(6例)、股内侧肌(6例)、缝匠肌(5例)、大收肌(5例)、股直肌(4例)、半膜肌(4例)、半腱肌(4例)、股二头肌(4例)、股薄肌(3例)、长收肌(2例)。12块肌肉脂肪浸润评分由高到低分别为股外侧肌(3.2分)、股中间肌(3.2分)、股内侧肌(3.0分)、大收肌(3.0分)、臀大肌(2.7分)、股二头肌(2.2分)、半膜肌(2.1分)、半腱肌(1.8分)、股直肌(1.5分)、缝匠肌(1.3分)、股薄肌(0.8分)、长收肌(O.7分)。6例患者均表现为远端肌肉受累为主,脂肪浸润对称。3例出现水肿,1例患者仅表现为股外侧肌受累,另外2例患者12块肌肉均表现为不同程度的水肿。6例患者中5例出现萎缩,12块肌肉萎缩受累频率由高到低分别为股外侧肌(5例)、股中间肌(5例)、股内侧肌(4例)、大收肌(4例)、半膜肌(2例)、股直肌(1例)、缝匠肌(1例),臀大肌、长收肌、股薄肌、半腱肌及股二头肌未见萎缩。结论sIBM主要的MRI表现为脂肪浸润及萎缩,最常受累的肌肉为股外侧肌、股中间肌、股内侧肌及大收肌,并且以远端受累更常见。 Objective To investigate the characteristic MRI features of sporadic inclusion-body myositis (sIBM). Methods Clinical and MR imaging data of 6 patients with sIBM diagnosed by muscle biopsy from May 2013 to November 2014 were retrospectively analyzed. All patients showed insidious onset of lower limb muscle weakness and diagnosed as sIBM by muscle biopsies. All patients were evaluated by the score of the severity of fatty infiltration, inflammation and atrophy in MRI. Results All patients were observed fatty infiltration with different degrees. The fatty infiltration in thighs was characterized in a decreasing order of frequency: gluteus maximus (6 cases), vastuslateralis (6 cases), vastusintermedius (6 cases), vastusmedialis (6 cases), sartorius (5 cases), adductor magnus (5 cases), rectus femoris (4 cases), semi- membranosus (4 cases), semi-tendinosus (4 cases), biceps femoris (4 cases), gracilis (3 cases), adductor longus(2 cases).The fatty infiltration in thighs was characterized in a decreasing order of severity: vastuslateralis (3.2 points), vastusintermedius (3.2 points), vastusmedialis (3.0 points), adductor magnus (3.0 points), gluteus maximus (2.7 points), bicepsfemoris (2.2 points), semi-membranosus (2.1 points), semi- tendinosus (2.1 points), rectus femoris (1.5 points), sartorius (1.3 points), gracilis (0.8 points), adductor longus (0.7 points). All patients showed the features of distal distribution andsymmetry. Inflammation was observed in 3 patients. 1 patient only involved the vastuslateralis, the other 2 patients were observed muscle inflammation with different degrees in 12 muscles. Atrophy was observed in 5 patients. The atrophy in thighs was characterized in a decreasing order of frequency: vastuslateralis (5 cases), vastusintermedius (5 cases), vastusmedialis (4 cases), adductor magnus (4 cases), semi-membranosus (2 cases), rectus femoris (1 cases),sartorius (1 cases) and gluteus maximus; there was no atrophy in adductor longus, graeilis,semi-tendinosus, biceps femoris. Conclusion The MRI characteristic manifestations of sIBM is fatty infiltration and atrophy in the distal portion, particularly involving the vastuslateralis, vastusintermedius, vastusmedialis and adductor magnus.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2016年第5期376-379,共4页 Chinese Journal of Radiology
关键词 磁共振成像 肌炎 Magnetic resonance imaging Myositis
  • 相关文献

参考文献12

  • 1Oldfors A, Lindberg C. Diagnosis, pathogenesis and treatment of inclusion body myositis[J]. Cun'OpinNeurol, 2005, 18(5): 497-503.
  • 2Yunis EJ, Samaha FJ. Inclusion body myositis[J]. Lab Invest, 1971, 25(3): 240-248.
  • 3Carpenter S, Karpati G, Heller I, et al. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy[J]. Neurology, 1978, 28(1): 8-17.
  • 4Engel WK, Askanas V. Inclusion- body myositis: clinical, diagnostic, and pathologic aspects[J]. Neurology, 2006, 66(2 Suppl 1): $20-$29. DOhlO.1212/Ol.wnl.O000192260.33106. bb.
  • 5Cox FM, Reijnierse M, van Rijswijk CS, et al. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis[J]. Rheumatology(Oxford), 2011, 50(6): 1153 - 1161. DOI: 10.1093/rheumatology/kerO01.
  • 6Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis[J]. J Rheumatol, 2002, 29(9): 1897-1906.
  • 7Tasca G, Monforte M, De Fino C, et al. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis[J]. Muscle Nerve, 2015, 52(6): 956-962. DOI:lO.1002/mus.24661.
  • 8牛丰南,金庆文,张平,侯熙德,丁新生,牛琦.伴有破碎红纤维的包涵体肌炎的临床及病理学特点(附1例报告)[J].临床神经病学杂志,2013(1):19-21. 被引量:4
  • 9Hoogendijk JE, Amato AA, Lecky BR, et al. ll9th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands[J]. Neuromuscul Disord, 2004, 14(5): 337-345. DOhl0.1016/j. nmd.2004.02.006.
  • 10Kim HK, Laor T, Horn PS, et al. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments[J]. Radiology, 2010, 255 (3): 899-908. DOI: 10.1148/radiol. 10091547.

二级参考文献13

  • 1吕海东,张三军,李增富,秦东香,钱琪,韩凯,马晓丽,宋学云,杨斌.包涵体肌炎的临床与病理特点(附2例报告)[J].临床神经病学杂志,2007,20(3):188-190. 被引量:4
  • 2Tawil R, Griggs RC. Inclusion body myositis[J]. Curr Opin Rheumatol, 2002, 14: 653.
  • 3Scott AP, Laing NG, Mastaglia F, et al. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex [ J ]. J Neuroimmunol,2011,235 :77.
  • 4O'Hanlon TP, Carrick DM, Arnett FC, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians [ J ]. Medicine, 2005,84:338.
  • 5Needham M, Mastaglia FL, Garlepp MJ. Genetics of inclusion-body myositis[J]. Muscle Nerve, 2007, 35:549.
  • 6Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies[J]. Ann Neurol, 1995, 38: 705.
  • 7Oldfors A, Moslemi AR, Jonasson L, et al. Mitochondrial abnormalities in inclusion-body myositis[ J-. Neurology, 2006, 66(Suppl1) : S49.
  • 8Eisenberg I, Novershtem N, Itzhaki Z, et al. Mitochondrial processes are impaired in hereditary inclusion body myopathy [ J ]. Hum Mol Genet, 2008, 17 : 3663.
  • 9Dubourg O, Wanschitz J, Maisonobe T, et al. Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis [J]. Acta Myol,2011,30 : 103.
  • 10Nogalska A, D'Agostino C, Engel WK, et al. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers[J]. Acta Neuropathol, 2010, 120: 661.

共引文献3

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部